Clinical Trial Update: Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating adapalene 0.3% - benzoyl peroxide 2.5% gel for acne vulgaris and atrophic acne scars has completed with results posted in 2019…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris
• Atrophic Acne Scars

Drugs mentioned

• adapalene 0.3% - benzoyl peroxide 2.5% gel (adapalene and benzoyl peroxide combination)

Snippet

Sponsor: Galderma R&D | Conditions: Acne Vulgaris, Atrophic Acne Scars | Phase 4 | Status: COMPLETED | Results posted: 2019-11-15